Genotypic to Phenotypic Resistance Discrepancies Identified Involving P-Lactamase Genes, blaKPC, blaIMP, blaNDM-1, and blaVIM in Uropathogenic Klebsiella pneumoniae

• Published in: Infection and drug resistance Vol. 13; p. 2863
• Main Authors: Urmi, Umme Laila, Nahar, Shamsun, Rana, Masud, Sultana, Fahmida, Jahan, Nusrat, Hossain, Billal, Alam, Mohammed Shah, Mosaddek, Abu Syed Md, Mckimm, Judy, Rahman, Nor Azlina A, Islam, Salequl, Haque, Mainul
• Format: Journal Article
• Language: English
• Published: Dove Medical Press Limited 31.08.2020
• Subjects: Amino acids; Analysis; Antibacterial agents; Beta lactam antibiotics; Beta lactamases; Genes; Genetic research; Health aspects; Microbial drug resistance; Pneumonia; Urinary tract infections; United Kingdom; Bangladesh; Malaysia
• ISSN: 1178-6973; 1178-6973
• DOI: 10.2147/IDR.S262493

Introduction: Klebsiella pneumoniae carbapenemase (KPC) belongs to the Group-A [beta]-lactamases that incorporate serine at their active site and hydrolyze various penicillins, cephalosporins, and carbapenems. Metallo-beta-lactamases (MBLs) are group-B enzymes that contain one or two essential zinc ions in the active sites and hydrolyze almost all clinically available [beta]-lactam antibiotics. Klebsiella pneumoniae remains the pathogen with the most antimicrobial resistance to KPC and MBLs. Methods: This research investigated the blaKPC, and MBL genes, namely, blaIMP, blaVIM, and blaNDM-1 and their phenotypic resistance to K pneumoniae isolated from urinary tract infections (UTI) in Bangladesh. Isolated UTI K pneumoniae were identified by API-20E and 16s rDNA gene analysis. Their phenotypic antimicrobial resistance was examined by the Kirby-Bauer disc diffusion method, followed by minimal inhibitory concentration (MIC) determination. blaKPC, blaIMP, blaNDM-1, and blaVIM genes were evaluated by polymerase chain reactions (PCR) and confirmed by sequencing. Results: Fifty-eight K pneumoniae were identified from 142 acute UTI cases. Their phenotypic resistance to amoxycillin-clavulanic acid, cephalexin, cefuroxime, ceftriaxone, and imipenem were 98.3%, 100%, 96.5%, 91.4%, 75.1%, respectively. Over half (31/58) of the isolates contained either blaKPC or one of the MBL genes. Individual prevalence of blaKPC, blaIMP, blaNDM-1, and blaVIM were 15.5% (9), 10.3% (6), 22.4% (13), and 19% (11), respectively. Of these, eight isolates (25.8%, 8/31) were found to have two genes in four different combinations. The co-existence of the ESBL genes generated more resistance than each one individually. Some isolates appeared phenotypically susceptible to imipenem in the presence of blaKPC, blaIMP, blaVIM, and blaNDM-1 genes, singly or in combination. Conclusion: The discrepancy of genotype and phenotype resistance has significant consequences for clinical bacteriology, precision in diagnosis, the prudent selection of antimicrobials, and rational prescribing. Heterogeneous phenotypes of antimicrobial susceptibility testing should be taken seriously to avoid inappropriate diagnostic and therapeutic decisions. Keywords: Klebsiella pneumoniae, blaKPC, blaIMP, blaNDM-1, blaVIM, co-resistance, heteroresistance, urinary tract infections, Bangladesh